Skip to main content

ETF comparison

IBB vs IXJ

Both Healthcare.

iShares Biotechnology ETF · iShares Global Healthcare ETF

Holdings overlap

Weighted by ISIN/CUSIP
8.3 %

9 positions appear in both funds. Buying equal dollars of IBB and IXJ would leave roughly 8.3% of each dollar exposed to the same underlying securities.

IBB unmatched 91.6% Shared 8.3% IXJ unmatched 91.3%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In IBB only
239 positions
Shared
9 positions
In IXJ only
101 positions

Side by side

IBB

iShares Biotechnology ETF

iShares · Healthcare

72 composite / 100
Expense ratio
0.44%
Net assets
$11.20B
TTM yield
0.16%
Top-10 conc.
44.7%
IXJ

iShares Global Healthcare ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.38%
Net assets
$4.32B
TTM yield
1.32%
Top-10 conc.
47.8%

Sub-score comparison

56
Cost
62
85
Tax efficiency
83
100
Liquidity
84
50
Concentration
46
—
Tracking quality
—
IBB sub-score IXJ

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

IXJ is 6 bps cheaper than IBB. On a $100,000 position that's about $60/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs IXJ.

Top shared holdings

9 shared in total
# Holding In IBB In IXJ Overlap
1 Amgen, Inc. 7.83% 2.54% 2.54%
2 Gilead Sciences, Inc. 6.84% 2.04% 2.04%
3 Vertex Pharmaceuticals, Inc. 8.08% 1.64% 1.64%
4 Regeneron Pharmaceuticals, Inc. 4.91% 0.81% 0.81%
5 Biogen, Inc. 2.47% 0.41% 0.41%
6 Moderna, Inc. 1.98% 0.32% 0.32%
7 Incyte Corp. 1.75% 0.25% 0.25%
8 Charles River Laboratories International, Inc. 0.84% 0.14% 0.14%
9 Bio-Techne Corp. 0.86% 0.14% 0.14%

Only in IBB

239 total
  • Argenx SE 3.76%
  • Alnylam Pharmaceuticals, Inc. 3.12%
  • Natera, Inc. 2.89%
  • Revolution Medicines, Inc. 2.78%
  • Illumina, Inc. 2.07%
  • Insmed, Inc. 1.78%
  • BeOne Medicines Ltd. 1.77%
  • United Therapeutics Corp. 1.73%
  • Roivant Sciences Ltd. 1.43%
  • Neurocrine Biosciences, Inc. 1.30%

Only in IXJ

101 total
  • ELI LILLY AND COMPANY 10.93%
  • JOHNSON & JOHNSON 7.04%
  • ABBVIE INC. 5.12%
  • UNITEDHEALTH GROUP INCORPORATED 4.40%
  • MERCK & CO., INC. 4.12%
  • ASTRAZENECA PLC 3.76%
  • Roche Holding AG 3.75%
  • Novartis AG 3.71%
  • THERMO FISHER SCIENTIFIC INCORPORATED 2.42%
  • ABBOTT LABORATORIES 2.05%

Percentages are holdings overlap with the named fund.

Open IBB or IXJ at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.